To gain further insight into the functional properties of CD163-expressing MCs at MS lesion rims, we focused on IL10 and C1QA expression as two signature markers for regulatory (IL10) [41] and pro-inflammatory (C1QA) functions [1, 16, 33, 52]. This evidence concerns the gene CD163 and myeloid sarcoma.